The AAK1 Knockout HeLa Polyclonal Cells product comprises a CRISPR/Cas9-edited polyclonal population of HeLa cells featuring targeted disruption of the AAK1 gene, which encodes the serine/threonine kinase adaptor-associated kinase 1. This polyclonal knockout pool serves as a loss-of-function model to investigate the role of AAK1 in clathrin-mediated endocytosis and its impact on downstream signaling pathways. Unlike single-cell-derived clones, the polyclonal format preserves population-level heterogeneity while ensuring robust gene disruption, making it suitable for assays requiring physiologically relevant cellular responses. The use of CRISPR/Cas9 technology enables efficient and heritable ablation of AAK1 expression without the need for continuous antibiotic selection, facilitating straightforward integration into standard experimental workflows.
The host HeLa cell line is an HPV18-positive cervical adenocarcinoma epithelial model, widely employed in biomedical research due to its robust growth characteristics and well-characterized signaling networks. These cells exhibit functional inactivation of the tumor suppressors p53 and Rb through the actions of the viral oncoproteins E6 and E7, respectively, creating a permissive environment for studying oncogenic processes. The epithelial origin of HeLa cells and their inherent ability to form tight junctions and undergo collective migration make them particularly valuable for investigating cell polarity, adhesion, and metastatic behavior. In the context of endocytosis research, HeLa cells express key components of the clathrin machinery and respond to growth factor stimulation, providing a physiologically relevant background for dissecting AAK1-dependent trafficking events.
AAK1 functions as a critical regulator of clathrin-coated pit maturation by phosphorylating the mu2 subunit of the AP2 adaptor complex (AP2M1) on threonine 156. This phosphorylation event enhances AP2 binding to cargo receptors and clathrin, thereby promoting the assembly and internalization of coated vesicles. AAK1 is activated by upstream signals, including EGF stimulation, and interacts with the adaptor protein Numb and the clathrin heavy chain (CLTC) within the endocytic machinery. Through this mechanism, AAK1 governs the internalization of diverse cell surface receptors, such as the epidermal growth factor receptor (EGFR) and transferrin receptor (TFRC), and modulates downstream signaling outputs involving the Notch and Wnt pathways. The kinase thus serves as a molecular switch linking extracellular cues to intracellular trafficking and signal transduction.
In HeLa cells, disruption of AAK1 is expected to attenuate clathrin-mediated endocytosis, leading to reduced internalization of EGFR and other cargo, and consequently altering receptor tyrosine kinase signaling dynamics. Given the HeLa cell??s reliance on EGFR and related pathways for proliferation and migration, this knockout model provides a direct means to assess the contribution of endocytic regulation to cancer cell behavior. Furthermore, the AAK1 knockout HeLa polyclonal cells offer a platform for studying the role of endocytosis in viral entry, as AAK1 has been implicated in the internalization of viruses such as SARS-CoV-2. The polyclonal nature of the knockout population allows researchers to study the overall impact of AAK1 loss without clonal artifacts, better reflecting the complexity of endogenous cellular responses.
This product is suited for a broad range of experimental applications, including quantitative analysis of transferrin uptake by flow cytometry, visualization of clathrin-coated pit dynamics via TIRF microscopy, and immunofluorescence-based assessment of EGFR internalization. The cells can be employed in scratch wound assays to evaluate the role of AAK1 in collective cell migration and in drug sensitivity testing with small-molecule AAK1 inhibitors for potential therapeutic applications. Additionally, the knockout line serves as a valuable tool for investigating the cellular mechanisms underlying neuropathic pain, Parkinson??s disease, and schizophrenia, as well as for dissecting host factors involved in COVID-19 pathogenesis. For technical inquiries or to discuss custom applications, please contact Ascent Research.
